TTM
−$1.13B
YoY change
+34.0%
5Y CAGR
—
Peak year (2010)
−$8.09M
Cumulative operating income
−$5.67B
Operating Income history chart for Insmed (INSM) from 1999 to 2025
Latest: −$1.18B
Operating Income growth chart for Insmed (INSM) from 1999 to 2025
Latest: +34.0%
Operating Income history table for Insmed (INSM) from 1999 to 2025
| 2025 | −$1.18B | +34.0% | −$298.48M | ||
| 2024 | −$878.25M | +23.8% | −$168.63M | ||
| 2023 | −$709.63M | +55.2% | −$252.31M | ||
| 2022 | −$457.32M | +21.9% | −$82.23M | ||
| 2021 | −$375.09M | +41.4% | −$109.86M | ||
| 2020 | −$265.23M | +12.7% | −$29.99M | ||
| 2019 | −$235.25M | -23.5% | +$72.09M | ||
| 2018 | −$307.34M | +62.7% | −$118.42M | ||
| 2017 | −$188.92M | +9.0% | −$15.52M | ||
| 2016 | −$173.40M | +47.6% | −$55.91M | ||
| 2015 | −$117.49M | +34.5% | −$30.13M | ||
| 2014 | −$87.36M | +58.8% | −$32.35M | ||
| 2013 | −$55.02M | +29.6% | −$12.58M | ||
| 2012 | −$42.44M | -31.2% | +$19.28M | ||
| 2011 | −$61.72M | +662.7% | −$53.63M | ||
| 2010 | −$8.09M | -6.7% | +$582.00K | ||
| 2009 | −$8.67M | -39.8% | +$5.74M | ||
| 2008 | −$14.41M | -29.5% | +$6.03M | ||
| 2007 | −$20.44M | -62.4% | +$33.93M | ||
| 2006 | −$54.37M | +98.2% | −$26.94M | ||
| 2005 | −$27.43M | +0.0% | −$9.00K | ||
| 2004 | −$27.43M | +159.1% | −$16.84M | ||
| 2003 | −$10.59M | -71.4% | +$26.44M | ||
| 2002 | −$37.02M | -7.9% | +$3.16M | ||
| 2001 | −$40.19M | -50.7% | +$41.35M | ||
| 2000 | −$81.53M | +902.9% | −$73.41M | ||
| 1999 | −$8.13M | — | — |
- 2025−$1.18B+34.0%
- 2024−$878.25M+23.8%
- 2023−$709.63M+55.2%
- 2022−$457.32M+21.9%
- 2021−$375.09M+41.4%
- 2020−$265.23M+12.7%
- 2019−$235.25M-23.5%
- 2018−$307.34M+62.7%
- 2017−$188.92M+9.0%
- 2016−$173.40M+47.6%
- 2015−$117.49M+34.5%
- 2014−$87.36M+58.8%
- 2013−$55.02M+29.6%
- 2012−$42.44M-31.2%
- 2011−$61.72M+662.7%
- 2010−$8.09M-6.7%
- 2009−$8.67M-39.8%
- 2008−$14.41M-29.5%
- 2007−$20.44M-62.4%
- 2006−$54.37M+98.2%
- 2005−$27.43M+0.0%
- 2004−$27.43M+159.1%
- 2003−$10.59M-71.4%
- 2002−$37.02M-7.9%
- 2001−$40.19M-50.7%
- 2000−$81.53M+902.9%
- 1999−$8.13M—
Operating Income values are taken from Insmed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Insmed (INSM)
According to Insmed's latest reported financial statements, the company's current operating income (TTM) is −$1.13B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Insmed (INSM) most recent annual operating income stands at −$1.18B (2025) – surged 34.0% year-over-year.
−$8.09M stands as the all-time-high annual operating income, posted in 2010, against a low of −$1.18B during 2025.
Insmed Operating Income by Year
Insmed Operating Income 2025: −$1.18B
Insmed operating income in 2025 was −$1.18B, surged 34.0% from 2024. This figure represents the lowest annual value in the available history.
Insmed Operating Income 2024: −$878.25M
2024's operating income for Insmed came in at −$878.25M, grew 23.8% from 2023.
Insmed Operating Income 2023: −$709.63M
Insmed posted operating income of −$709.63M in 2023, surged 55.2% from 2022.
Insmed Operating Income 2022: −$457.32M
In 2022, Insmed reported operating income of −$457.32M, grew 21.9% from 2021.
Insmed Operating Income 2021: −$375.09M
Insmed operating income in 2021 was −$375.09M.
See more financial history for Insmed (INSM).
Sector peers by Operating Income
Healthcare peers of Insmed (INSM), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation